Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions

NCT ID: NCT01403480

Last Updated: 2011-07-27

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 600 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2008-01-31
• Study Completion Date: 2011-02-28

Brief Summary

Basal Cell Carcinoma (BCC) is the most common malignant growth in the world. Treatment is primarily surgical with the goal of excising the growth in its entirety. When pathology results show that this has not been achieved, a re-excision is routinely performed. This study examines retrospectively the percentage of re-excisions of BCC that actually proved to be positive (exhibited growth) among those re-excisions performed at Rambam Healthcare Campus and Zvulun Community Medical Center during the years 2008-10.

Conditions

Basal Cell Carcinoma

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: RETROSPECTIVE

Eligibility Criteria

Inclusion Criteria

All patients that underwent an incomplete BCC excision during the years 2008-2010.

Exclusion Criteria

Patients that underwent an incomplete BCC excision and were subsequently referred to undergo a MOHS procedure.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Rambam Health Care Campus

OTHER

Sponsor Role: lead

Responsible Party

Head, Plastic and Reconstructive Surgery Department, Rambam Healthcare Campus

Other Identifiers

0064-11-RMB-CTIL

Identifier Type: -

Identifier Source: org_study_id